Broadview Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-18,800
Closed -$264K 88
2019
Q1
$264K Buy
+18,800
New +$247K 0.07% 87
2016
Q3
Sell
-117,850
Closed -$2.51M 104
2016
Q2
$2.51M Buy
117,850
+500
+0.4% +$9.42K 0.38% 67
2016
Q1
$2.07M Buy
117,350
+96,390
+460% +$1.44M 0.3% 74
2015
Q4
$316K Buy
+20,960
New +$322K 0.04% 97
2013
Q4
Sell
-307,375
Closed -$6.57M 105
2013
Q3
$6.57M Buy
307,375
+141,000
+85% +$2.9M 0.76% 60
2013
Q2
$3.22M Buy
+166,375
New +$3.63M 0.45% 72

Other funds holding PTEN

Broadview Advisors's PTEN Position: Q2 2019 in Review

Broadview Advisors sold out of Patterson-UTI (PTEN) in Q2 2019, closing a stake of 18,800 shares — an estimated $264K sold.

Broadview Advisors first reported a position in PTEN in Q2 2013 and held it in 6 quarters. The position peaked at $6.57M in Q3 2013. 278 funds tracked by Wall St. Rank hold PTEN as of Q2 2019.

  • Broadview Advisors reported no remaining Patterson-UTI position as of Q2 2019 after selling out during the quarter.
  • Broadview Advisors sold 18,800 Patterson-UTI shares in Q2 2019, an estimated $264K.
  • Broadview Advisors first reported a position in Patterson-UTI in Q2 2013 and held it in 6 quarters.
  • Broadview Advisors's Patterson-UTI position peaked at $6.57M in Q3 2013.
  • 278 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2019.

Based on Broadview Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.